diabetestalk.net

Chantix And Diabetes

Type 1 & 2 Diabetes: How To Win At Quitting Smoking Cigarettes

Type 1 & 2 Diabetes: How To Win At Quitting Smoking Cigarettes

Smokers are often consulted by healthcare professionals who want to support them in quitting smoking. While there are more former smokers than current smokers, In 2014, It was estimated that 40 million Americans were still addicted to cigarettes because quitting smoking is so difficult. Withdrawing from cigarettes can be such a painful endeavor that many smokers abandon their plan. In fact, withdrawal symptoms are the number one reason quitters return to smoking. Smokers may have to try to stop five or six times before they are smoke-free. But there are ways they can successfully stop smoking. Here are some recommendations for how smokers can quit their nicotine addiction. Nicotine replacement therapy: Nicotine patches, gum and lozenges are among some of the products available for people looking for help in quitting smoking. These products contain nicotine, but none of the other harmful chemicals found in cigarettes. They work by releasing small amounts of nicotine in the body to help ease the symptoms of withdrawal. Patches and gum come in various doses of nicotine, so quitters slowly lessen their nicotine cravings rather than going cold turkey. There are some side effects of using NRT, including headaches, nausea and trouble sleeping. Non-nicotine medications: Chantix (varenicline tartrate) and Zyban (buproprion) are two prescription-based bills that are FDA approved for the purposes of smoking cessation. Chantix works by affecting the site in the brain affected by nicotine. It provides some relief from withdrawal symptoms, and it blocks the effects of nicotine if a quitter resumes smoking. Zyban is a low-dose formula of the same medication used in the anti-depressant Wellbutrin. It also helps to reduce the cravings and withdrawal symptoms. Side effects for Chantix in Continue reading >>

Chantix Diabetes

Chantix Diabetes

Chantix is an FDA-approved medication that can help people stop smoking by blocking the brain's receptors from enjoying nicotine. However, within first year that Chantix was publicly used (from 2006 to 2007), hundreds of patients contacted the FDA and reported that taking Chantix caused them to experience serious side effects, including heart problems, depression and diabetes. In fact, during this period, 544 patients reported experiencing problems with their glycemic control due to having abnormally low levels of insulin in their blood. Although quitting smoking can affect people's glycemic control and, consequently, mock the symptoms of diabetes, taking Chantix can clearly amplify this effect in some patients. What is Diabetes? Diabetes, clinically known as diabetes mellitus, is an incurable condition in which the pancreas is unable to produce enough or any insulin, a hormone that regulates blood sugar and energy levels. Without enough insulin, blood sugar levels drop, and diabetics will start to experience: anxiety clamminess confusion heart palpitations seizures sweatiness tremors unconsciousness While those born with diabetes are said to have "type 1 diabetes," anyone who develops this condition later in life — such as after extreme weight gain or after taking a certain medication — is said to have "type 2 diabetes." Type 1 diabetes requires regular insulin shots as part of the lifelong treatment of the condition. In contrast, most people with type 2 diabetes can manage their condition by eating healthfully and exercising, rather than by taking insulin. Diabetes Symptoms: Is Chantix causing you to develop diabetes? The best way to prevent the serious side effects associated with taking Chantix is to regularly visit your doctor and to be aware of the symptoms of Continue reading >>

Chantix Problems

Chantix Problems

Chantix is marketed in the U.S. as a drug to help you stop smoking. Researchers at the National Institutes of Health say it may also help alcoholics stop drinking. Researchers say the drug, which goes by the generic name varenicline, treats alcoholism in much the same way as it does nicotine addiction. It stimulates an area of the brain that provides the pleasure derived from both drinking alcohol and smoking tobacco. No pleasure, no urge to drink. "Drinking and smoking often co-occur, and given their genetic and neurochemical similarities, it is perhaps unsurprising that a smoking cessation treatment might serve to treat alcohol problems," said Dr. Raye Litten of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) . "Our study is the first multi-site clinical trial to test the effectiveness and safety of varenicline in a population of smokers and nonsmokers with alcohol dependence." Ziller and colleagues conducted a clinical trial with 200 adults with drinking problems. They say they found the drug reduced the urge to drink. 18 million potential patients NIH estimates about 18 million people in the U.S. have problems controlling their alcohol consumption. The researchers, writing in the Journal of Addiction Medicines, suggest Chantix should be considered as a tool to combat alcoholism. Chantix, however, is known to have some side effects which can be severe. Problems reported with the drug have given some consumers pause. Chantix already carries a “black box” warning on its label. But researchers at Harvard, Johns Hopkins and other institutions, say it might not be enough. Writing about their study in the journal PloS One in 2011, they said the drug's poor safety profile makes it unsuitable for first-line use among those who want to quit smoking. Accordi Continue reading >>

Chantix Side Effects By Likelihood And Severity

Chantix Side Effects By Likelihood And Severity

COMMON side effects If experienced, these tend to have a Less Severe expression Abnormal Dreams Chronic Trouble Sleeping Constipation Feel Like Throwing Up Gas Head Pain Throwing Up INFREQUENT side effects If experienced, these tend to have a Severe expression Angina Trouble Breathing If experienced, these tend to have a Less Severe expression Acute Infection Of The Nose, Throat Or Sinus Drowsiness Dry Mouth Excessive Sweating Feeling Weak Gastroesophageal Reflux Disease Increased Hunger Indigestion Intense Abdominal Pain Itching Loss Of Appetite Low Energy Nightmares Not Feeling Well Rash Runny Nose Sluggishness RARE side effects If experienced, these tend to have a Severe expression Abnormal Heart Rhythm Abnormal Liver Function Tests Anemia Behaving With Excessive Cheerfulness And Activity Chest Pain Delusions Depression Diabetes Erythema Multiforme Giant Hives Hallucination Having Thoughts Of Suicide Heart Attack High Blood Pressure Injury Panic Disorder Paranoia Problems Metabolizing Alcohol Psychosis Caused By A Drug Seizures Stevens-Johnson Syndrome Stroke Suicidal Thoughts Of Hurting Or Killing Others Transient Ischemic Attack Unconscious If experienced, these tend to have a Less Severe expression Aggressive Behavior Altered Interest In Having Sexual Intercourse Backache Cannot Focus Thoughts Cramps Diarrhea Disturbance Of Attention Dizzy Excess Urination Feeling Agitated Feeling Anger Toward Something Feeling Anxious Flu-Like Symptoms Heart Throbbing Or Pounding High Blood Sugar Hives Joint Pain Mood Changes Muscle Pain Nosebleed Peripheral Vascular Disease Problem Behavior Problem With Periods Problems With Eyesight Ringing In The Ears Sensation Of Spinning Or Whirling Sleep Disorder Sleepwalking Swollen Lymph Nodes Taste Problems Temporary Redness Of Face And Continue reading >>

Call Us For Additional Information :

Call Us For Additional Information :

Produced and distributed by Pfizer since 2006, Chantix® is a smoking cessation medication that is known to increase patients' risk of some severe side effects, including loss of glycemic control and type-2 diabetes. Although quitting smoking is known to affect people's ability to control their blood sugar levels, studies are finding that taking Chantix® can intensify this side effect and, in some patients, trigger the symptoms of type-2 diabetes. Given the severity of diabetes, it's vital that patients thinking of taking Chantix®: Discuss their complete medical history with their doctor before they start taking this medication. Learn about the risk factors and symptoms of Chantix®-related diabetes. Get regular checkups while taking Chantix® so their doctors can detect and treat Chantix® diabetes in its early stages (should it develop). Meet with a personal injury attorney, should they develop Chantix® diabetes, to learn more about their legal rights and possible claims to a Chantix® settlement. What is Type-2 Diabetes? Also known as "adult onset diabetes," type-2 diabetes is a condition in which blood sugar levels can't be naturally controlled because either: The body slowly becomes resistant to insulin; or The pancreas doesn't produce enough insulin. Although the obesity epidemic is one of the primary causes of type-2 diabetes, certain medications or underlying conditions can also cause people to develop type-2 diabetes at some point in life. In contrast, type-1 diabetes is a congenital condition (present since birth) in which a person is unable to produce enough, if any, insulin. Type-1 diabetics will need to take insulin as part of the lifelong treatment of their condition. Symptoms of Chantix® Diabetes Chantix® users may be losing their glycemic control an Continue reading >>

Chantix Diabetes Side Effects

Chantix Diabetes Side Effects

The Chantix lawyers at Saiontz & Kirk are no longer accepting new clients for potential lawsuits as a result of diabetes from Chantix. According to adverse drug event reports received by the FDA, there may be a connection between the use of Chantix and diabetes. The stop smoking drug has been linked with a number of reports involving loss of glycemic control, which includes new onset diabetes. While studies have not firmly established that Chantix causes diabetes, sufficient reports of problems associated with the use of the drug to raise substantial concerns within the medical community. Chantix (generic varenicline tartrate) is a prescription drug sold to help people quit smoking. It was approved by the U.S. Food and Drug Administration in May 2006 and has become one of the fastest growing medications in the country. Within the first two years the drug was on the market, concerns started to surface about a possible connection between Chantix and a variety of serious and potentially life threatening side effects. By late 2007, Chantix was one of the most frequently listed drugs associated with a wide variety of serious adverse event reports received by the FDA. This led an independent consumer watchdog group, The Institute for Safe Medication Practices, to conduct a detailed analysis of all reported problems associated with Chantix. An examination of adverse event reports received by the FDA between May 2006 and December 2007 revealed at least 544 reports suggesting Chantix side effects may have caused a loss of glycemic control, including a number of cases that contained symptoms and lab tests consistent with onset of diabetes. This likely represents only a small portion of the true number of adverse events experienced by users, as it is generally accepted that only a Continue reading >>

Pharmalot, Pharmalittle: Fda Approves Sanofi And Novo Diabetes Drugs

Pharmalot, Pharmalittle: Fda Approves Sanofi And Novo Diabetes Drugs

Hello, everyone, and how are you today? We are just fine, thank you. Another chilly and windy day has arrived here at the Pharmalot campus, where the official mascots are sprawled across the office furniture. As for us, we are going about our usual business, brewing cups of stimulation in the coffee kettle and foraging for interesting items. Speaking of which, here are some tidbits. Hope you have a wonderful day … Sanofi and Novo Nordisk both won US regulatory approval to sell new combination drugs to treat diabetes, Reuters notes. Novo’s Xultophy and Sanofi’s Soliqua both combine a long-lasting insulin with a so-called GLP-1 medicine that stimulates insulin production in the pancreas. Both drugs will be sold at discounts to the combined price of the individual components in hopes of boosting sales as insulin prices are under intense pressure in the key US market. A key issue in a coroner’s inquest being heard in Australia is why risks associated with Pfizer’s Chantix smoking cessation pill do not appear in the packaging, the Courier Mail reports. During the proceeding, which stems from concerns the pill caused a 22-year-old man to commit suicide, a Pfizer representative noted that the risk information is available online, so it can be updated. A US appeals court upheld AstraZeneca and Ranbaxy Laboratories’s victory in a lawsuit accusing them of reaching an illegal deal to delay the launch of a generic version of the Nexium heartburn drug. A jury agreed the deal was large, unjustified, and unreasonably anticompetitive. But even without the deal, the jury also decided AstraZeneca would not have allowed Ranbaxy to sell a generic Nexium before the May 2014 patent expiration date. The Food and Drug Administration lifted a hold on two AstraZeneca trials that were Continue reading >>

Drug Safety Oversight Board Meeting - March 19, 2015

Drug Safety Oversight Board Meeting - March 19, 2015

The following Drug Safety Communications (DSCs) have posted since the January 15, 2015 DSB meeting: February 25, 2015: Multi-dose Diabetes Pen Devices – FDA is requiring additional label warnings prohibiting sharing of these injectable medicines. This is being done in an effort to reduce the serious risk of infection spread through sharing of multi-dose diabetes pen devices intended for single patient use only. Insulin pens and pens for other injectable diabetes medicines should never be shared among patients, even if the needle is changed. Sharing pens can result in the spread of serious infections from one patient to another. To promote safe use, FDA is requiring that pens and packaging containing multiple doses of insulin and other injectable diabetes medicines display a warning label stating “For single patient use only.” March 3, 2015: Testosterone Products – FDA cautions that prescription testosterone products are approved only for men who have low testosterone levels caused by certain medical conditions. The benefit and safety of these medications have not been established for the treatment of low testosterone levels due to aging, even if a man’s symptoms seem related to low testosterone. FDA is requiring that the manufacturers of all approved prescription testosterone products change their labeling to clarify the approved uses of these medications. FDA is also requiring these manufacturers to add information to the labeling about a possible increased risk of heart attacks and strokes in patients taking testosterone. Health care professionals should prescribe testosterone therapy only for men with low testosterone levels caused by certain medical conditions and confirmed by laboratory tests. March 9, 2015: Chantix (varenicline) – FDA is warning that t Continue reading >>

Fda Warns About Chantix Reactions

Fda Warns About Chantix Reactions

The stop-smoking drug varenicline (Chantix) has been widely advertised on television. The commercials encourage people to ask their doctor if Chantix is right for them. But this week, the Food and Drug Administration issued a new safety announcement about Chantix. In it, the agency warns that the medication can change the way people react to alcohol. There are reports of aggressive or violent behavior associated with this combination. Some people have amnesia for their actions. Readers have reported some frightening situations in which a person taking Chantix reacted very badly after a few drinks. In one tragic occurrence, a soldier using Chantix to try to quit smoking committed murder and suicide after drinking. Danger of Seizures In addition, the FDA warns that Chantix can trigger seizures, even in some people who have no history of epilepsy. As important as it is to quit smoking-and it is one of the most important steps to be taken to prevent disease-some people cannot tolerate the side effects of Chantix. It is crucial to understand the range of reactions that some people experience before starting on this drug. Continue reading >>

Is Chantix Bad For Diabetics?

Is Chantix Bad For Diabetics?

I am a diabetic and have smoked for many years, but want to quit. I read about the anti-smoking drug Chantix and heard people say it really works. I tried it and after a week my smoking decreased, but my blood sugar levels went up. I finally had to stop taking this drug. Is there a reason my levels would go up? — Suzanne, Tennessee Congratulations on your desire to stop smoking. As I often say to my patients, it is the most important decision you will make to stay healthy. Chantix (vareniciline) has been shown to be more effective than other anti-smoking aids, including Zyban (bupropion) and nicotine replacement therapy. And, yes, in the rare individual, Chantix has been associated with increased blood glucose levels. The mechanism for this effect is not known. Chantix also has other side effects of greater concern, namely, depressed mood and suicidal ideation. Therefore, close monitoring is very important if you decide to take this drug. You should discuss with your doctor the best way to support your decision to stop smoking. I believe that the most effective smoking cessation therapy is a combination of nicotine replacement therapy (for example, patches or gum), medication such as Chantix or Zyban, and psychotherapy. I wish you success. Learn more in the Everyday Health Diabetes Center. Continue reading >>

Fda Safety Changes For Diabeta And Chantix

Fda Safety Changes For Diabeta And Chantix

The US Food and Drug Administration (FDA) has approved safety labeling revisions to warn of the risk for serious effects from Chantix and DiaBeta. The FDA approved new safety labeling revisions due to the psychiatric effects in patients taking varenicline as an aid to smoking cessation; drug interactions that may potentiate the hypoglycemic effects of glyburide in patients with Type 2 diabetes mellitus. Varenicline (Chantix) Linked to Risk for Serious Neuropsychiatric Events On July 1, the FDA approved safety labeling revisions for varenicline tartrate tablets (Chantix, Pfizer, Inc) that include a black-box warning regarding the risk for serious neuropsychiatric events. The warning was based on postmarketing reports of changes in mood (including depression and mania), psychosis, hallucinations, paranoia, delusions, homicidal ideation, hostility, agitation, anxiety, and panic, as well as suicidal ideation, suicide attempt, and completed suicide. These events have occurred in patients with and without preexisting psychiatric disease. Although some neuropsychiatric symptoms may have occurred in association with nicotine withdrawal, they were also reported in patients who had not yet discontinued smoking. The majority of cases occurred during treatment, but some also were reported after withdrawal of varenicline therapy. Because varenicline may cause worsening of current psychiatric illness (even if it is under control) and cause recurrence of prior illness, patients should inform their healthcare provider of any such illness before initiating varenicline therapy. The FDA notes that patients with serious psychiatric illnesses (e.g., schizophrenia, bipolar disorder, and major depressive episodes) were excluded from clinical trials of varenicline, and the drug’s safety in t Continue reading >>

Chantix® & Diabetes

Chantix® & Diabetes

The use of Chantix® has been associated with a number of adverse events consistent with new-onset diabetes. Lawsuits are currently being considered. What’s the problem? Diabetes, clinically known as diabetes mellitus, is an incurable condition in which the pancreas is unable to produce enough or any insulin, a hormone that regulates blood sugar and energy levels. Without enough insulin, blood sugar levels drop, and diabetics will start to experience: anxiety clamminess confusion heart palpitations seizures sweatiness tremors unconsciousness An examination of adverse event reports received by the FDA between May 2006 and December 2007 revealed at least 544 reports suggesting Chantix side effects may have caused a loss of glycemic control, including a number of cases that contained symptoms and lab tests consistent with onset of diabetes. This likely represents only a small portion of the true number of adverse events experienced by users, as it is generally accepted that only about 1% to 10% of all serious events are reported to the FDA. While many of the reported adverse events in this category were a result of weight gain or weight loss, which could be expected among a population of people quitting smoking, a large number of the cases had classic indications of new onset diabetes mellitus from Chantix. This included reports of elevated blood glucose, hunger, thirst and frequent urination. The best way to prevent the serious side effects associated with taking Chantix is to regularly visit your doctor and to be aware of the symptoms of Chantix-related health problems. Since the symptoms of diabetes are clearly general, any Chantix user experiencing these health changes should visit their doctor for blood tests and a proper diabetes diagnosis. Continue reading >>

More in diabetes